KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.58 $2.30 Thursday, 25th Apr 2024 CTMX stock ended at $1.60. This is 1.84% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.54% from a day low at $1.58 to a day high of $1.64.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Feb 13, 2024 $1.38 $1.46 $1.38 $1.41 452 385
Feb 12, 2024 $1.50 $1.57 $1.48 $1.53 142 194
Feb 09, 2024 $1.48 $1.56 $1.48 $1.52 187 358
Feb 08, 2024 $1.43 $1.50 $1.43 $1.46 209 364
Feb 07, 2024 $1.46 $1.46 $1.43 $1.44 128 469
Feb 06, 2024 $1.45 $1.51 $1.45 $1.46 130 000
Feb 05, 2024 $1.48 $1.48 $1.44 $1.45 142 277
Feb 02, 2024 $1.52 $1.53 $1.46 $1.48 232 405
Feb 01, 2024 $1.53 $1.54 $1.49 $1.53 221 299
Jan 31, 2024 $1.54 $1.60 $1.51 $1.53 144 599
Jan 30, 2024 $1.63 $1.63 $1.51 $1.57 255 256
Jan 29, 2024 $1.58 $1.65 $1.55 $1.61 297 754
Jan 26, 2024 $1.54 $1.59 $1.52 $1.59 204 481
Jan 25, 2024 $1.53 $1.56 $1.52 $1.53 166 146
Jan 24, 2024 $1.65 $1.65 $1.52 $1.53 523 835
Jan 23, 2024 $1.63 $1.64 $1.59 $1.61 250 483
Jan 22, 2024 $1.65 $1.65 $1.60 $1.63 219 625
Jan 19, 2024 $1.67 $1.67 $1.62 $1.63 250 568
Jan 18, 2024 $1.62 $1.70 $1.60 $1.68 422 355
Jan 17, 2024 $1.63 $1.68 $1.58 $1.63 404 598
Jan 16, 2024 $1.73 $1.73 $1.64 $1.67 345 023
Jan 12, 2024 $1.69 $1.74 $1.62 $1.73 392 098
Jan 11, 2024 $1.67 $1.70 $1.60 $1.69 308 032
Jan 10, 2024 $1.62 $1.69 $1.57 $1.67 371 780
Jan 09, 2024 $1.58 $1.63 $1.55 $1.59 475 816
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT